New hope for advanced cancers? first human trial launches
NCT ID NCT06427941
First seen Jun 25, 2026 · Last updated Jul 30, 2026 · Updated 5 times
Summary
This early-stage study is testing a new drug called BGB-B2033, alone or with other drugs, in people with advanced liver, stomach, or lung cancers. The goal is to see if it is safe and how well it works. About 392 participants will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BGB-B2033, tislelizumab, bevacizumab
- What this could lead to
- If it works, this could point toward a new treatment option for certain advanced cancers like liver, stomach, and lung cancer.
- What could go wrong
- This is a very early (Phase 1) study, so the drug may not work or could have serious side effects. It is also small and not yet tested in many people.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Anhui Provincial Hospital
RECRUITINGHefei, Anhui, 230000, China
-
Asan Medical Center
RECRUITINGSongpaGu, Seoul Teugbyeolsi, 05505, South Korea
-
Auckland City Hospital
RECRUITINGAuckland, 1023, New Zealand
-
Cancer Institute Hospital of Jfcr
RECRUITINGKotoku, Tokyo, 135-8550, Japan
-
Centre Hospitalier Universitaire Nantes Hotel Dieu
RECRUITINGNantes, 44000, France
-
Centro Gaucho Integrado de Oncologia Hospital Mae de Deus
RECRUITINGPorto Alegre, 90110-270, Brazil
-
Cha Bundang Medical Center, Cha University
RECRUITINGBundangGu SeongnamSi, Gyeonggi-do, 13496, South Korea
-
Chongqing University Cancer Hospital
RECRUITINGChongqing, Chongqing Municipality, 400030, China
-
Chungbuk National University Hospital
RECRUITINGCheongju-si, Chungcheongbukdo, 28644, South Korea
-
City of Hope Chicago Cancer Center
RECRUITINGZion, Illinois, 60099, United States
-
City of Hope National Medical Center
RECRUITINGDuarte, California, 91010-3012, United States
-
City of Hope Phoenix Cancer Center
RECRUITINGGoodyear, Arizona, 85338, United States
-
Fondazione Policlinico Universitario Agostino Gemelli
RECRUITINGRoma, 00168, Italy
-
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto
RECRUITINGSão José do Rio Preto, 15090-000, Brazil
-
Guangxi Medical University Cancer Hospital Wuxiang Branch
RECRUITINGNanning, Guangxi, 530201, China
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, Heilongjiang, 150000, China
-
Hopital Beaujon
RECRUITINGClichy, 92110, France
-
Hospital Da Bahia
RECRUITINGSalvador, 41810-011, Brazil
-
Hospital Oncologico
RECRUITINGRio Piedras, 00935, Puerto Rico
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, 410013, China
-
Icesp Instituto Do Cancer Do Estado de Sao Paulo Octavio Frias de Oliveira
RECRUITINGSão Paulo, 01246-000, Brazil
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94800, France
-
Iov Istituto Oncologico Veneto Irccs
RECRUITINGPadova, 35128, Italy
-
Irccs Humanitas Research Hospital
RECRUITINGRozzano, 20089, Italy
-
Irccs Istituto Nazionale Tumori Fondazione Pascale
RECRUITINGNaples, 80131, Italy
-
Kindai University Hospital
RECRUITINGSakai, Osaka, 590-0197, Japan
-
Lishui Central Hospital
RECRUITINGLishui, Zhejiang, 323000, China
-
Memorial Sloan Kettering Cancer Center Mskcc
RECRUITINGNew York, New York, 10065-6800, United States
-
Mengchao Hepatobiliary Hospital of Fujian Medical University
RECRUITINGFuzhou, Fujian, 350028, China
-
Nanfang Hospital of Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510515, China
-
Samsung Medical Center
RECRUITINGGangnamGu, Seoul Teugbyeolsi, 06351, South Korea
-
Scri Oncology Partners
RECRUITINGNashville, Tennessee, 37203-1503, United States
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, Gyeonggi-do, 13620, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, Seoul Teugbyeolsi, 03080, South Korea
-
Severance Hospital Yonsei University Health System
RECRUITINGSeodaemunGu, Seoul Teugbyeolsi, 03722, South Korea
-
Sichuan Cancer Hospital and Institute
RECRUITINGChengdu, Sichuan, 610041, China
-
The Affiliated Hospital of Xuzhou Medical University
RECRUITINGXuzhou, Jiangsu, 221000, China
-
The First Affiliated Hospital of Wenzhou Medical University
RECRUITINGWenzhou, Zhejiang, 325000, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310003, China
-
The Fourth Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, 050011, China
-
The Second Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
-
The Second Affiliated Hospital of Nanchang Universityhongjiaozhou Branch
RECRUITINGNanchang, Jiangxi, 330038, China
-
The University of Texas Md Anderson Cancer Center
RECRUITINGHouston, Texas, 77030-4009, United States
-
Tokyo Metropolitan Komagome Hospital
RECRUITINGBunkyoku, Tokyo, 113-8677, Japan
-
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430030, China
-
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430022, China
-
Upmc Hillman Cancer Center(Univ of Pittsburgh)
RECRUITINGPittsburgh, Pennsylvania, 15232-1309, United States
-
Zhujiang Hospital of Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill outsmart RAS-Mutant cancers?
- Could a personal coach at home boost energy for cancer patients?
- Can an IDO1 inhibitor boost immunotherapy against liver cancer?
- Personalized maintenance therapy: a smarter way to treat advanced cancer?
- Can a radioactive antibody light up hidden cancers on PET scans?
- Can a smart drug deliver a toxic payload directly to cancer cells?